Applied Biotechnology Institute
Publicly observedSan Luis Obispo, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | San Luis Obispo | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Applied Biotechnology Institute | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | XNMLFC55AWN3 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant30 Sept 2026Publicly observed
NIH SBIR/STTR award: Production in maize of low-cost heat stable forms of GLP-1 and GIP receptor agonists for treatment of diabetes and obesity
USD 288,221.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant14 Aug 2026Publicly observed
NIH SBIR/STTR award: Production of low-cost heat stable forms of adalimumab in maize for treatment of inflammatory bowel disease.
USD 299,936.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.